Study finds AI-OCT-based system noninferior for secondary diabetic macular edema detection

AI Summary

A study published in JAMA finds that an AI-based optical coherence tomography system for diabetic macular edema screening is noninferior to standard methods and reduces unnecessary referrals. This technology offers potential improvements in diabetic eye care.

Incorporation of an artificial intelligence-based-optical coherence tomography (AI-OCT) system as a secondary screening tool is noninferior to standard practice and can reduce unnecessary diabetic macular edema (DME) referrals, according to a study published online June 15 in the Journal of the American Medical Association.